141 related articles for article (PubMed ID: 30325729)
1. BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer.
Kladi-Skandali A; Sideris DC; Scorilas A
Clin Chem Lab Med; 2018 Dec; 57(2):276-287. PubMed ID: 30325729
[TBL] [Abstract][Full Text] [Related]
2. BCL2L12: a promising molecular prognostic biomarker in breast cancer.
Tzovaras A; Kladi-Skandali A; Michaelidou K; Zografos GC; Missitzis I; Ardavanis A; Scorilas A
Clin Biochem; 2014 Dec; 47(18):257-62. PubMed ID: 25230343
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of Bcl2L12 and its short variant in breast cancer lymph node metastasis.
Chien ST; Yang TF; Yang MC; Hsu CM; Hong YR; Lee TM
Oncol Rep; 2015 Aug; 34(2):961-71. PubMed ID: 26082034
[TBL] [Abstract][Full Text] [Related]
4. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors.
Talieri M; Diamandis EP; Katsaros N; Gourgiotis D; Scorilas A
Thromb Haemost; 2003 Jun; 89(6):1081-8. PubMed ID: 12783122
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
Thomadaki H; Talieri M; Scorilas A
Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810
[TBL] [Abstract][Full Text] [Related]
6. Positive BCL2L12 expression predicts favorable prognosis in patients with laryngeal squamous cell carcinoma.
Giotakis AI; Lazaris AC; Kataki A; Kontos CK; Giotakis EI
Cancer Biomark; 2019; 25(2):141-149. PubMed ID: 31104007
[TBL] [Abstract][Full Text] [Related]
7. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
Kontos CK; Papadopoulos IN; Scorilas A
Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
[TBL] [Abstract][Full Text] [Related]
8. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Geomela PA; Kontos CK; Yiotakis I; Scorilas A
J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer.
Florou D; Papadopoulos IN; Scorilas A
Biochem Biophys Res Commun; 2010 Jan; 391(1):214-8. PubMed ID: 19903463
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.
Kontos CK; Scorilas A
Gene; 2012 Aug; 505(1):153-66. PubMed ID: 22664385
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology.
Adamopoulos PG; Kontos CK; Tsiakanikas P; Scorilas A
Cancer Lett; 2016 Apr; 373(1):119-129. PubMed ID: 26797417
[TBL] [Abstract][Full Text] [Related]
12. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A
Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536
[TBL] [Abstract][Full Text] [Related]
13. Identification of Two Novel Circular RNAs Deriving from
Karousi P; Artemaki PI; Sotiropoulou CD; Christodoulou S; Scorilas A; Kontos CK
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238574
[TBL] [Abstract][Full Text] [Related]
14. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.
Fendri A; Kontos CK; Khabir A; Mokdad-Gargouri R; Scorilas A
Mol Med; 2011; 17(3-4):163-71. PubMed ID: 21152697
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis regulator Bcl-2 is an independent prognostic marker for worse overall survival in triple-negative breast cancer patients.
Ozretic P; Alvir I; Sarcevic B; Vujaskovic Z; Rendic-Miocevic Z; Roguljic A; Beketic-Oreskovic L
Int J Biol Markers; 2018 Jan; 33(1):109-115. PubMed ID: 28777433
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.
Michaelidou K; Ardavanis A; Scorilas A
Breast Cancer Res Treat; 2015 Jul; 152(2):323-36. PubMed ID: 26099606
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
[TBL] [Abstract][Full Text] [Related]
18. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
Papageorgiou SG; Kontos CK; Pappa V; Thomadaki H; Kontsioti F; Dervenoulas J; Papageorgiou E; Economopoulos T; Scorilas A
Oncologist; 2011; 16(9):1280-91. PubMed ID: 21737576
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.
Callagy GM; Pharoah PD; Pinder SE; Hsu FD; Nielsen TO; Ragaz J; Ellis IO; Huntsman D; Caldas C
Clin Cancer Res; 2006 Apr; 12(8):2468-75. PubMed ID: 16638854
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer.
Mathioudaki K; Scorilas A; Papadokostopoulou A; Xynopoulos D; Arnogianaki N; Agnanti N; Talieri M
Biol Chem; 2004 Sep; 385(9):779-83. PubMed ID: 15493871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
